{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:16:27Z","timestamp":1774332987740,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1097\/md.0000000000010718","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T02:38:23Z","timestamp":1525833503000},"page":"e0718","source":"Crossref","is-referenced-by-count":7,"title":["Immunotherapy for pulmonary squamous cell carcinoma and colon carcinoma with pembrolizumab"],"prefix":"10.1097","volume":"97","author":[{"given":"Yoshihiro","family":"Nozawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Oosugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-52-20210309","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-52-20210309","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.immuni.2016.04.023","article-title":"Targeting T cell coreceptors for cancer therapy","volume":"44","author":"Callahan","year":"2016","journal-title":"Immunity"},{"key":"R3-52-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"R4-52-20210309","first-page":"5132","article-title":"Proliferative activity of intratumoral CD8 (+) T lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity","volume":"61","author":"Nakano","year":"2001","journal-title":"Cancer Res"},{"key":"R5-52-20210309","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-52-20210309","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00262-003-0388-5","article-title":"Prognostic value of the CD4+\/CD8+ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells","volume":"52","author":"Diederichsen","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"R7-52-20210309","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/cncr.21283","article-title":"The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase","volume":"104","author":"Piras","year":"2005","journal-title":"Cancer"},{"key":"R8-52-20210309","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Mahmoud","year":"2011","journal-title":"J Clin Oncol"},{"key":"R9-52-20210309","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/bcr3148","article-title":"CD8+ lymphocyte in filtration is an independent favorable prognostic indicator in basal-like breast cancer","volume":"14","author":"Liu","year":"2012","journal-title":"Breast Cancer Res"},{"key":"R10-52-20210309","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells with in human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"R11-52-20210309","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with nonsmall-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J Clin Oncol"},{"key":"R12-52-20210309","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/annonc\/mdu452","article-title":"PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics","volume":"25","author":"Massi","year":"2014","journal-title":"Ann Oncol"},{"key":"R13-52-20210309","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13000-015-0414-x","article-title":"PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis","volume":"10","author":"Leite","year":"2015","journal-title":"Diagn Pathol"},{"key":"R14-52-20210309","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4143\/crt.2016.066","article-title":"Overexpression of PD-L1 and PD-L2 is associated with poor prognosis in patients with hepatocellular carcinoma","volume":"49","author":"Jung","year":"2016","journal-title":"Cancer Res Treat"},{"key":"R15-52-20210309","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1158\/2326-6066.CIR-15-0302","article-title":"Immune-derived PD-L1 gene expression defines a subgroup of stage II\/III Colorectal Cancer patients with favorable prognosis who may be harmed by adjuvant chemotherapy","volume":"4","author":"Dunne","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"R16-52-20210309","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/gutjnl-2016-311421","article-title":"Tumour CD274 (PD-L1) expression and T cells in colorectal cancer","volume":"66","author":"Masugi","year":"2017","journal-title":"Gut"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000010718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:08:27Z","timestamp":1620961707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201805110-00052"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":16,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000010718","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}